≡ Data On Investigational Compounds Being Co-Developed By Tibotec For The Treatment Of Chronic Hepatitis C Presented At EASL 2008 Part 4
[iii] Risk factor in support of hepatitis C doubling after liver transplantation. J Viral Hepat. 2007 Nov;14 Suppl 1:89-96. Roche B, Samuel D. Assistance Publique-Hopitaux de Paris, Ḫ̫pital Paul Brousse, Centre Ḫ̩pato-Biliaire; and INSERM, Unit̮̩ 785; and Universit̮̩ Paris-Sud, UMR-S 785, Villejuif, France.
[iv] World Cialis Professional Organization (WHO). Fact chip of […]
